Net Cash Provided by (Used in) Operating Activities |
-285K |
USD |
+76.3% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
-811K |
USD |
-19884% |
Q1 2023 |
Q1 2023 |
Net Cash Provided by (Used in) Investing Activities |
0 |
USD |
|
Q1 2024 |
Q1 2024 |
Common Stock, Shares Authorized |
150M |
shares |
0% |
Q2 2024 |
Q2 2024 |
Common Stock, Shares, Issued |
108M |
shares |
+0.74% |
Q2 2024 |
Q2 2024 |
Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q2 2024 |
Q2 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
41.7K |
USD |
|
Q1 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
12.4M |
USD |
-9.44% |
Q2 2024 |
Q2 2024 |
Deferred Tax Assets, Gross |
3.6M |
USD |
+58.4% |
Q4 2023 |
FY 2023 |
Payments to Acquire Property, Plant, and Equipment |
52.7K |
USD |
-89.5% |
Q1 2024 |
Q1 2024 |
Property, Plant and Equipment, Gross |
14.6M |
USD |
-44.8% |
Q2 2024 |
Q2 2024 |
Deferred Tax Assets, Operating Loss Carryforwards |
646K |
USD |
+110% |
Q4 2023 |
FY 2023 |
Preferred Stock, Shares Issued |
1.69M |
shares |
|
Q4 2022 |
Q2 2024 |
Current Income Tax Expense (Benefit) |
0 |
USD |
|
Q2 2024 |
Q2 2024 |
Preferred Stock, Shares Authorized |
10M |
shares |
0% |
Q2 2024 |
Q2 2024 |
Additional Paid in Capital |
64.1M |
USD |
+0.46% |
Q2 2024 |
Q2 2024 |
Depreciation, Depletion and Amortization |
114K |
USD |
+34.5% |
Q2 2024 |
Q2 2024 |
Deferred Tax Assets, Net of Valuation Allowance |
487K |
USD |
+90.2% |
Q4 2023 |
FY 2023 |
Interest Expense |
15.1K |
USD |
+173% |
Q4 2022 |
FY 2022 |
Preferred Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q2 2024 |
Q2 2024 |